. 2020 Jan 13;2020:6108575. doi: 10.1155/2020/6108575

Table 3.

Fecal LAB populations on days 0, 15, and 30 after L. rhamnosus BSL and L. rhamnosus R23 administration.

Experimental groups	LAB population (log CFU/g)
Experimental groups	Day 0	Day 15	Day 30
N	9.52 ± 0.04^a	9.34 ± 0.05^a	9.15 ± 0.28^a
DM	9.53 ± 0.24^b	9.15 ± 0.10^ab	8.63 ± 0.03^a
DM + BSL	9.37 ± 0.02^a	9.50 ± 0.29^a	9.68 ± 0.14^b
DM + R23	9.21 ± 0.05^a	9.41 ± 0.05^a	9.80 ± 0.15^b

The values are expressed as the means ± SD (n = 6). Means within a row with different superscript letters are significantly different (P < 0.05). N = nondiabetic control group; DM = diabetic control group; DM + BSL = STZ treated with L. rhamnosus BSL; DM + R23 = STZ treated with L. rhamnosus R23.